Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,618,778
+$513,580 QoQ
Shares Held
51,508
+1.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
#919
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monte Financial Group, LLC holds $28,595,491 across 7 Drug Manufacturers - General names. MRK ranks #3 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
33,979 | $8,629,646 | |
| 2 | NVS |
Novartis AG
|
44,535 | $6,979,525 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
51,508 | $6,618,778 | |
| 4 | PFE |
Pfizer Inc
|
173,412 | $4,175,760 | |
| 5 | AZN |
Astrazeneca PLC
|
9,226 | $1,749,434 | |
| 6 | NVO |
Novo Nordisk A S
|
4,982 | $238,837 | |
| 7 | AMGN |
Amgen Inc
|
562 | $203,511 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,618,778 | 51,508 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,105,198 | 50,754 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,353,523 | 50,860 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $4,312,239 | 51,379 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $3,885,964 | 49,090 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $5,665,920 | 63,123 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $5,433,398 | 54,618 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,453,832 | 48,026 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,851,530 | 47,266 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $6,248,228 | 47,353 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $5,167,657 | 47,401 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $4,429,732 | 43,028 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,864,957 | 42,161 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,794,571 | 45,066 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $5,874,358 | 52,946 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $4,927,614 | 57,218 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $6,098,178 | 66,888 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $5,495,216 | 66,974 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,974,472 | 64,907 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $5,018,699 | 66,818 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $4,569,920 | 58,762 | Shares | Sole | 2021-10-25 | |
| 2021-03-31 | $4,431,598 | 57,486 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,908,320 | 47,779 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,975,380 | 47,925 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,878,797 | 50,159 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,398,053 | 44,165 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||